A network of experts in reproductive and children’s environmental health

PEHSU Grand Rounds Webinar

This webinar is part of an ongoing series of educational presentations by experts on issues that focus on current and emerging aspects of pediatric and reproductive environmental health.

Prioritizing Toxic Chemicals in Children’s Consumer Products - December 14, 2016

These presentations focus on the impact of environmental exposures to chemicals on human health at the vulnerable stages of in utero and pediatric development. A number of topics will be included – all of them relevant to questions of exposure and health effects, with consideration of risk reduction. Speakers will include physicians and PhD subject matter experts, as well as individuals with expertise in areas such as home assessment, laboratory analysis, and risk communication.

Learning Objectives

By the end of this module, participants should be able to:
  • Learn how chemical in consumer products are regulated in Washington State
  • Be able to discuss the benefits and shortcomings of this approach
  • Become familiar with the Children’s Safe Product Act and the types of data required to be reported
  • Be able to discuss the toxicity and exposure related concerns relevant to prioritizing chemicals in consumer products
  • Learn how Toxic Substances Control Act Reform is expected to impact children’s consumer product regulation

Presenters: Elaine Faustman, PhD and Marissa Smith

Faustman_121416Elaine Faustman, PhD
Director of the Institute of Risk Analysis and Risk Communication
University of Washington, School of Public Health
Seattle, WA
Region 10 PEHSU

Dr. Elaine M. Faustman, Professor and Director of the Institute of Risk Analysis and Risk Communication, School of Public Health, University of Washington, Seattle. Dr. Faustman directs the NIEHS/EPA-funded Center for Children’s Health Research and she served as PI for NICHD-funded Pacific Northwest Center for the National Children’s Study. She is an elected fellow of the American Association for the Advancement of Science and the Society for Risk Analysis. She has served on the USEPA Science Advisory Board and chaired the National Academy of Sciences Committee on Developmental Toxicology. She has also served on the National Advisory Environmental Health Sciences Council, NIEHS-NTP Board of Scientific Counselors and Committee on Alternative Toxicology Methods, National Academy of Sciences Committee in Toxicology and the Institute of Medicine Upper Reference Levels of Nutrient Subcommittee of the Food and Nutrition Board. She is Secretary General for the International Union of Toxicology(IUTOX) and a member of the International Science Council (ICSU) World Data Systems Advisory Board. For over 2 decades she has been involved and directed Stakeholder forums and Community Based Participatory Research for DOE, EPA and NIH. Her research expertise is on integrative scientific approaches including identifying molecular mechanisms of developmental, reproductive, and neuro toxicants, characterizing in vitro techniques for toxicology assessment, and developing biological and exposure based dose-response models. She has over 200 peer reviewed research publications and reports.

MarissaSmith_121416Marissa Smith
PhD Student
University of Washington, School of Public Health
Seattle, WA
Region 10 PEHSU
Ms. Smith earned her MS in Environmental Toxicology in 2012 from the University of Washington. Since then she has worked as a research scientist at the Institute for Risk Analysis and Risk Communication. Her research has focused on the reproductive and developmental impacts chemical and nonchemical stressors, including social stress and pesticide exposure. She is interested in the lifestage specific impacts of toxic chemicals during development. As a current PhD student, her research focuses on the health impacts of regulations on chemicals in children’s consumer products. This work is supported by an EPA Star Graduate Student Fellowship Award (FP-91779601-0).

Webinar Recording and Materials 

 Preview.png Take_Course_Button.png

Continuing Education 

To receive continuing education (CE):
FEES: No fees are charged for CDC’s CE activities.



CME activities with Joint Providers: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Centers for Disease Control and Prevention and the American College of Medical Toxicology. The Centers for Disease Control and Prevention is accredited by the (ACCME®) to provide medical education for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Regarding WC2588 - The Centers for Disease Control and Prevention designates this live educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™.

Regarding WD2588 - The Centers for Disease Control and Prevention designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™.

Other Credit types:

  • CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.This activity provides 1.0 contact hours.
  • CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
  • CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
  • For Certified Public Health Professionals (CPH)
    CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.org.


This material was supported by the American College of Medical Toxicology (ACMT) and funded (in part) by the cooperative agreement FAIN: U61TS000238-03 from the Agency for Toxic Substances and Disease Registry (ATSDR). 

Acknowledgement: The U.S. Environmental Protection Agency (EPA) supports the PEHSU by providing partial funding to ATSDR under Inter-Agency Agreement number DW-75-92301301. Neither EPA nor ATSDR endorse the purchase of any commercial products or services mentioned in PEHSU publications

DISCLOSURE: In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.

CDC, our planners, presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters with the exception of Charles A. McKay and he wishes to disclose that he is a member of the Scientific Advisory Council, Environmental Health Research Foundation (EHRF). EHRF addresses issues related to biomonitoring, a topic that is also relevant to some of the activities in the Grand Round Series that might be discussed in future sessions. EHRF receives funding from sources that includes industry. Dr. McKay has reviewed and written material for EHRF, that could create a perceived conflict of interest regarding environmental chemical exposure assessment/measurement.

Planning committee discussed conflict of interest with Dr. Charles A. McKay to ensure there is no bias. Content will not include any discussion of the unlabeled use of a product or a product under investigational use. CDC does not accept commercial support.